These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28456609)

  • 1. Computational modeling for cardiac safety pharmacology analysis: Contribution of fibroblasts.
    Gao X; Engel T; Carlson BE; Wakatsuki T
    J Pharmacol Toxicol Methods; 2017 Sep; 87():68-73. PubMed ID: 28456609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: A computational study.
    Xie Y; Garfinkel A; Camelliti P; Kohl P; Weiss JN; Qu Z
    Heart Rhythm; 2009 Nov; 6(11):1641-9. PubMed ID: 19879544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of integrated in silico transmural ventricular wedge preparation models of human non-failing and failing hearts for safety evaluation of drug candidates.
    Kubo T; Ashihara T; Tsubouchi T; Horie M
    J Pharmacol Toxicol Methods; 2017; 83():30-41. PubMed ID: 27546811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological modeling of fibroblasts and their interaction with myocytes.
    Sachse FB; Moreno AP; Abildskov JA
    Ann Biomed Eng; 2008 Jan; 36(1):41-56. PubMed ID: 17999190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross - site comparison of excitation-contraction coupling using impedance and field potential recordings in hiPSC cardiomyocytes.
    Bot CT; Juhasz K; Haeusermann F; Polonchuk L; Traebert M; Stoelzle-Feix S
    J Pharmacol Toxicol Methods; 2018; 93():46-58. PubMed ID: 29940218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of early afterdepolarization under healthy or hypertrophic cardiomyopathy conditions in the human ventricular endocardial myocyte: In silico study using 109 torsadogenic or non-torsadogenic compounds.
    Christophe B
    Toxicol Appl Pharmacol; 2022 Mar; 438():115914. PubMed ID: 35150662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of disease state on arrhythmic event detection by action potential modelling in cardiac safety pharmacology.
    Christophe B; Crumb WJ
    J Pharmacol Toxicol Methods; 2019; 96():15-26. PubMed ID: 30580044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of the dynamic regulation of cardiac electrophysiology by K
    Meier S; Grundland A; Dobrev D; Volders PGA; Heijman J
    J Physiol; 2023 Jul; 601(13):2711-2731. PubMed ID: 36752166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
    Zeng H; Roman MI; Lis E; Lagrutta A; Sannajust F
    J Pharmacol Toxicol Methods; 2016; 81():217-22. PubMed ID: 27222351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of BK(Ca)-channel activity in human cardiac fibroblasts to electrical coupling of cardiomyocytes-fibroblasts.
    Wang YJ; Sung RJ; Lin MW; Wu SN
    J Membr Biol; 2006; 213(3):175-85. PubMed ID: 17483867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CiPA: Ongoing testing, future qualification procedures, and pending issues.
    Cavero I; Holzgrefe H
    J Pharmacol Toxicol Methods; 2015; 76():27-37. PubMed ID: 26159293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G
    Kofron CM; Kim TY; King ME; Xie A; Feng F; Park E; Qu Z; Choi BR; Mende U
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H810-H827. PubMed ID: 28710068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico analysis of the contribution of cardiomyocyte-fibroblast electromechanical interaction to the arrhythmia.
    Kursanov A; Balakina-Vikulova NA; Solovyova O; Panfilov A; Katsnelson LB
    Front Physiol; 2023; 14():1123609. PubMed ID: 36969594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multi-Domain Fibroblast/Myocyte Coupling in the Cardiac Tissue: A Theoretical Study.
    Greisas A; Zlochiver S
    Cardiovasc Eng Technol; 2016 Sep; 7(3):290-304. PubMed ID: 27150222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.
    Burstein B; Qi XY; Yeh YH; Calderone A; Nattel S
    Cardiovasc Res; 2007 Dec; 76(3):442-52. PubMed ID: 17720149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative.
    Huang H; Pugsley MK; Fermini B; Curtis MJ; Koerner J; Accardi M; Authier S
    J Pharmacol Toxicol Methods; 2017 Sep; 87():11-23. PubMed ID: 28408211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillation.
    Aguilar M; Qi XY; Huang H; Comtois P; Nattel S
    Biophys J; 2014 Nov; 107(10):2444-55. PubMed ID: 25418313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of iCell cardiomyocytes using single-cell RNA-sequencing methods.
    Schmid C; Wohnhaas CT; Hildebrandt T; Baum P; Rast G
    J Pharmacol Toxicol Methods; 2020; 106():106915. PubMed ID: 32871229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.
    Jans D; Callewaert G; Krylychkina O; Hoffman L; Gullo F; Prodanov D; Braeken D
    J Pharmacol Toxicol Methods; 2017 Sep; 87():48-52. PubMed ID: 28549786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.